女性の健康市場：年齢、流通チャネル、用途別-2025-2030年の世界予測

女性の健康市場は、2023年に432億3,000万米ドルと評価され、2024年には469億9,000万米ドルに達すると予測され、CAGR 8.97％で成長し、2030年には789億米ドルに達すると予測されています。

女性の健康市場には、ライフステージを通じて女性特有の健康ニーズに対応することを目的とした幅広い製品とサービスが含まれます。この分野には、リプロダクティブ・ヘルス、更年期障害、骨粗鬆症、栄養不足などの分野を対象とした医薬品、医療機器、ウェルネス製品、診断、ホリスティック・ヘルス・サービスなどが含まれます。女性の健康の必要性は、乳がん、婦人科疾患、メンタルヘルスなどの状態に影響を与える明確な生物学的およびホルモン学的要因に根ざしており、それによって専門的な製品や治療が必要とされます。市場は、ヘルスケア施設、在宅ケア、専門クリニックにおけるアプリケーションによって牽引され、10代の少女、若い女性、妊娠中の女性、高齢者を含む広範なエンドユーザー層に対応しています。市場の成長に影響を与える主な要因としては、慢性疾患の罹患率の上昇、ヘルスケアに対する意識の高まり、ヘルスケア提供における技術の進歩などが挙げられます。

女性の高齢化と予防ヘルスケア重視の高まりにより、個別化医療と遠隔医療プラットフォームのようなデジタルヘルスソリューションに大きなビジネスチャンスが眠っています。企業は、AI主導の診断やウェアラブル・ヘルス・トラッカーに投資することで、こうした動向を活用することができます。さらに、自然でオーガニックな健康ソリューションへのシフトは、イノベーションのための成長スペースを提供します。しかし、市場は厳しい規制環境、高い研究開発コスト、ヘルスケアへのアクセスを制限する社会経済格差などの課題に直面しています。

技術革新のための最良の分野としては、特にホルモンや生殖器系の疾患に対する、個別化された非侵襲的診断ツールの開発や、患者のエンゲージメントとケアの継続性を高めるためのデジタル・ヘルス・ソリューションの統合が挙げられます。市場はダイナミックで、消費者の嗜好の変化や規制の変更に伴い、継続的な適応と研究が必要となります。企業は、イノベーションを促進し、市場への浸透を向上させるために、パートナーシップやコラボレーションに注力すべきです。また、女性のヘルスリテラシーを向上させ、知識のギャップを埋め、情報に基づいた意思決定を支援することも重要です。持続的な成長のためには、企業は女性の健康ソリューションのアクセシビリティとアフォーダビリティに積極的に取り組み、多様な社会経済グループに対応できるようにすべきです。

市場力学：急速に進化する女性の健康市場の主要市場インサイトを公開

女性の健康市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 女性におけるホルモンバランスの乱れと慢性疾患の増加
  • スーパーフードのトレンドの高まりと女性向けマルチビタミンの利用可能性の増加
  • 自然食品や植物由来の健康補助食品に対する女性の傾倒
• 市場抑制要因
  • 臨床治療費の高騰
• 市場機会
  • ホルモン障害の治療薬開発のための研究開発活動の活発化
  • 女性の健康を改善するために世界各国の政府が開始した好意的な政策
• 市場の課題
  • 薬剤摂取に伴う副作用

ポーターの5つの力：女性の健康市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：女性の健康市場における外部からの影響の把握

外部マクロ環境要因は、女性の健康市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析女性の健康市場における競合情勢の把握

女性の健康市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス女性の健康市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、女性の健康市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨女性の健康市場における成功への道筋を描く

女性の健康市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 女性のホルモンバランスの乱れや慢性疾患の増加
    • スーパーフードのトレンド上昇と女性向けマルチビタミンの入手しやすさの向上
    • 天然および植物由来の健康サプリメントに対する女性の傾向
  • 抑制要因
    • 臨床治療の高額な費用
  • 機会
    • ホルモン障害の治療薬開発に向けた研究開発活動の活発化
    • 世界中の政府が改善のために開始した好ましい政策女性の健康
  • 課題
    • 薬物摂取に伴う副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 女性の健康市場年齢別

• 13～17歳
• 18～35歳
• 36歳以上

第7章 女性の健康市場：流通チャネル別

• 病院
• オンライン
• 小売り

第8章 女性の健康市場：用途別

• 避妊薬
• 子宮内膜症と子宮筋腫
• ホルモン性不妊症
• 閉経
• 多嚢胞性卵巣症候群
• 閉経後骨粗鬆症

第9章 南北アメリカの女性の健康市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の女性の健康市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの女性の健康市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 女性の健康スタートアップ Iron Healthが450万米ドルでスタート。
  • Onsite女性の健康とVolpara Healthが全国的なパートナーシップを発表。
  • Kiran Mazumdar Shawが女性の健康プラットフォームGytree.comに投資します。
  • Bharat Serums and Vaccinesは、女性の健康セグメントにおける存在感を高めるために、Firstline PharmaとGenomicsを買収します。
  • Unified Women'sヘルスケアが更年期ケアプラットフォームGennevを買収。
  • カーライルとPAIが女性のヘルスケアに投資。
  • Myovant SciencesとPfizerは、子宮内膜症に伴う中度から重度の痛みの管理を目的とした1日1回投与の治療MYFEMBREEの米国FDA承認を取得しました。
  • FemTec HealthがNutrimedyを買収し、女性の健康スイートにパーソナライズされた栄養機能を追加しました。
  • HempStreetがGynicaとの戦略的パートナーシップを発表。
  • オルガノンはオランダで長期避妊薬の生産を大幅に拡大する予定です。
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AbbVie Inc.
• Agile Therapeutics, Inc.
• Alembic Pharmaceuticals Ltd.
• Amgen Inc.
• Apothecus Pharmaceutical Corp.
• Ar-Ex Laboratories Pvt. Ltd.
• AstraZeneca PLC
• AVA Sciences by FemTec Health Inc.
• Bayer AG
• Bharat Serums and Vaccines Ltd.
• Boston Imaging
• Cipla Limited
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Ferring B.V.
• GE HealthCare
• Gennev, Inc. by Unified Women's Healthcare
• Hologic, Inc.
• Johnson & Johnson Services, Inc.
• Lupin Limited
• Mankind Pharma Ltd.
• Mira by Quanovate Tech Inc.
• Mylan N.V. by Viatris
• Novartis AG
• Pfizer, Inc.
• Pregna International Ltd.
• Quest Diagnostics Incorporated
• Serum Institute Of India Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Siemens AG
• Sysmex Asia Pacific Pte Ltd.
• Teva Pharmaceutical Industries Ltd.
• The Himalaya Drug Company
• TherapeuticsMD, Inc.
• Thermo Fisher Scientific Inc.
• Torrent Pharmaceuticals Ltd.
• Triglobal Lifesciences（opc）Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
• FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. WOMEN'S HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. WOMEN'S HEALTH MARKET DYNAMICS
• TABLE 7. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 13-17 YEARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 18-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY 36 YEARS & ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY ENDOMETRIOSIS & UTERINE FIBROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY HORMONAL INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY MENOPAUSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL WOMEN'S HEALTH MARKET SIZE, BY POSTMENOPAUSAL OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. CANADA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. CHINA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. INDIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. ITALY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. POLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. QATAR WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 150. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

The Women's Health Market was valued at USD 43.23 billion in 2023, expected to reach USD 46.99 billion in 2024, and is projected to grow at a CAGR of 8.97%, to USD 78.90 billion by 2030.

The women's health market encompasses a broad range of products and services aimed at addressing the unique health needs of women throughout their life stages. This sector includes pharmaceuticals, medical devices, wellness products, diagnostics, and holistic health services targeting areas such as reproductive health, menopause, osteoporosis, and nutritional deficiencies. The necessity of women's health is rooted in the distinct biological and hormonal factors influencing conditions like breast cancer, gynecological disorders, and mental health, thereby necessitating specialized products and treatments. The market is driven by applications in healthcare facilities, homecare, and specialized clinics, catering to an expansive end-users demographic, including teenage girls, young women, pregnant women, and seniors. Key factors influencing market growth include the rising incidence of chronic conditions, increasing healthcare awareness, and technological advancements in healthcare delivery.

With the aging female population and increasing emphasis on preventive healthcare, significant opportunities lie in personalized medicine and digital health solutions like telemedicine platforms. Companies can capitalize on these trends by investing in AI-driven diagnostics and wearable health trackers. Additionally, the shift towards natural and organic health solutions offers a growing space for innovation. However, the market faces challenges such as stringent regulatory environments, high research and development costs, and socio-economic disparities limiting access to healthcare.

The best areas for innovation include the development of personalized, non-invasive diagnostic tools, especially for hormonal and reproductive disorders, and the integration of digital health solutions to enhance patient engagement and care continuity. The market is dynamic, with shifting consumer preferences and regulatory changes, necessitating continuous adaptation and research. Companies should focus on partnerships and collaborations to foster innovation and improve market penetration. It's also critical to enhance health literacy among women, bridging the knowledge gap to aid informed decision-making. For sustained growth, companies should proactively address the accessibility and affordability of women's health solutions, ensuring they cater to diverse socio-economic groups.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Women's Health Market

The Women's Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of hormonal imbalances and chronic diseases in women
  • Rising trend of superfood and increasing availability of multivitamins for women
  • Inclination of women towards natural and plant based health supplements
• Market Restraints
  • High cost of clinical treatments
• Market Opportunities
  • Rising R&D activities for drug development to treat the hormonal disorders
  • Favorable policies initiated by governments worlwide to improve women's health
• Market Challenges
  • Side-effects associated with consumption of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Women's Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Women's Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Women's Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Women's Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Women's Health Market

A detailed market share analysis in the Women's Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Women's Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Women's Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Women's Health Market

A strategic analysis of the Women's Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women's Health Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agile Therapeutics, Inc., Alembic Pharmaceuticals Ltd., Amgen Inc., Apothecus Pharmaceutical Corp., Ar-Ex Laboratories Pvt. Ltd., AstraZeneca PLC, AVA Sciences by FemTec Health Inc., Bayer AG, Bharat Serums and Vaccines Ltd., Boston Imaging, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Ferring B.V., GE HealthCare, Gennev, Inc. by Unified Women's Healthcare, Hologic, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mira by Quanovate Tech Inc., Mylan N.V. by Viatris, Novartis AG, Pfizer, Inc., Pregna International Ltd., Quest Diagnostics Incorporated, Serum Institute Of India Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Asia Pacific Pte Ltd., Teva Pharmaceutical Industries Ltd., The Himalaya Drug Company, TherapeuticsMD, Inc., Thermo Fisher Scientific Inc., Torrent Pharmaceuticals Ltd., and Triglobal Lifesciences (opc) Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Women's Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Age, market is studied across 13-17 Years, 18-35 Years, and 36 Years & Above.
• Based on Distribution Channel, market is studied across Hospital, Online, and Retail.
• Based on Application, market is studied across Contraceptives, Endometriosis & Uterine Fibroids, Hormonal Infertility, Menopause, Polycystic Ovary Syndrome, and Postmenopausal Osteoporosis.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
    • 5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
    • 5.1.1.3. Inclination of women towards natural and plant based health supplements
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of clinical treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
    • 5.1.3.2. Favorable policies initiated by governments worlwide to improve women's health
  • 5.1.4. Challenges
    • 5.1.4.1. Side-effects associated with consumption of drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Women's Health Market, by Age

• 6.1. Introduction
• 6.2. 13-17 Years
• 6.3. 18-35 Years
• 6.4. 36 Years & Above

7. Women's Health Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Hospital
• 7.3. Online
• 7.4. Retail

8. Women's Health Market, by Application

• 8.1. Introduction
• 8.2. Contraceptives
• 8.3. Endometriosis & Uterine Fibroids
• 8.4. Hormonal Infertility
• 8.5. Menopause
• 8.6. Polycystic Ovary Syndrome
• 8.7. Postmenopausal Osteoporosis

9. Americas Women's Health Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Women's Health Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Women's Health Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Women's health startup Iron Health launches with $4.5M.
  • 12.3.2. Onsite Women's Health and Volpara Health Announce National Partnership.
  • 12.3.3. Kiran Mazumdar Shaw invests in women's health platform Gytree.com.
  • 12.3.4. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women's health segment.
  • 12.3.5. Unified Women's Healthcare acquires menopause care platform Gennev.
  • 12.3.6. Carlyle and PAI on women's healthcare.
  • 12.3.7. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
  • 12.3.8. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
  • 12.3.9. HempStreet announces strategic partnership with Gynica.
  • 12.3.10. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AbbVie Inc.
• 3. Agile Therapeutics, Inc.
• 4. Alembic Pharmaceuticals Ltd.
• 5. Amgen Inc.
• 6. Apothecus Pharmaceutical Corp.
• 7. Ar-Ex Laboratories Pvt. Ltd.
• 8. AstraZeneca PLC
• 9. AVA Sciences by FemTec Health Inc.
• 10. Bayer AG
• 11. Bharat Serums and Vaccines Ltd.
• 12. Boston Imaging
• 13. Cipla Limited
• 14. Eli Lilly and Company
• 15. F. Hoffmann-La Roche Ltd.
• 16. Ferring B.V.
• 17. GE HealthCare
• 18. Gennev, Inc. by Unified Women's Healthcare
• 19. Hologic, Inc.
• 20. Johnson & Johnson Services, Inc.
• 21. Lupin Limited
• 22. Mankind Pharma Ltd.
• 23. Mira by Quanovate Tech Inc.
• 24. Mylan N.V. by Viatris
• 25. Novartis AG
• 26. Pfizer, Inc.
• 27. Pregna International Ltd.
• 28. Quest Diagnostics Incorporated
• 29. Serum Institute Of India Ltd.
• 30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 31. Siemens AG
• 32. Sysmex Asia Pacific Pte Ltd.
• 33. Teva Pharmaceutical Industries Ltd.
• 34. The Himalaya Drug Company
• 35. TherapeuticsMD, Inc.
• 36. Thermo Fisher Scientific Inc.
• 37. Torrent Pharmaceuticals Ltd.
• 38. Triglobal Lifesciences (opc) Pvt. Ltd.